LEADER 01676nam  2200505   450 
001 9910797651703321
005 20191011084620.0
010   $a1-910190-16-0
035   $a(CKB)3710000000484099
035   $a(SSID)ssj0001656490
035   $a(PQKBManifestationID)16437423
035   $a(PQKBTitleCode)TC0001656490
035   $a(PQKBWorkID)14984752
035   $a(PQKB)10181014
035   $a(Au-PeEL)EBL5897803
035   $a(OCoLC)939960472
035   $a(MiAaPQ)EBC5897803
035   $a(PPN)268867712
035   $a(EXLCZ)993710000000484099
100   $a20191011d2016      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aAlphaviruses $ecurrent biology /$fedited by Suresh Mahalingam, Lara J. Herrero, Insitute of Glycomics, Griffith University, Gold Coast, QLD, Australia, and Belinda L. Herring, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology,   Brisbane, QLD, Australia
210  1$aNorfolk, England :$cCaister Academic Press,$d[2016]
210  4$dİ2016
215   $a1 online resource (vii, 183 pages) $cillustrations
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a1-910190-15-2 
320   $aIncludes bibliographical references and index.
606   $aTogaviruses
615  0$aTogaviruses.
676   $a576.6484
702   $aHerring$b Belinda L.
702   $aHerrero$b Lara J.
702   $aMahalingam$b Suresh
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910797651703321
996   $aAlphaviruses$93847948
997   $aUNINA